Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production
暂无分享,去创建一个
P. Heeringa | A. von Borstel | W. Abdulahad | C. Stegeman | J. Sanders | A. Rutgers | G. Dekkema | Johanna Veldman | J. Veldman
[1] P. van Paassen,et al. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[2] P. Heeringa,et al. Evidence for enhanced Bruton’s tyrosine kinase activity in transitional and naïve B cells of patients with granulomatosis with polyangiitis , 2019, Rheumatology.
[3] P. Heeringa,et al. Circulating CD24hiCD38hi regulatory B cells correlate inversely with the ThEM17 cell frequency in granulomatosis with polyangiitis patients. , 2019, Rheumatology.
[4] V. Tesar,et al. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial , 2019, Annals of the rheumatic diseases.
[5] K. Campbell,et al. Therapy for Proliferative Lupus Nephritis. , 2018, Rheumatic diseases clinics of North America.
[6] D. Vergani,et al. Immunosuppressive drugs affect interferon (IFN)‐γ and programmed cell death 1 (PD‐1) kinetics in patients with newly diagnosed autoimmune hepatitis , 2017, Clinical and experimental immunology.
[7] J. Niles,et al. Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis , 2017, Arthritis & rheumatology.
[8] P. Heeringa,et al. Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis , 2016, Arthritis Research & Therapy.
[9] M. Liang,et al. Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity , 2016, Arthritis Research & Therapy.
[10] A. Bar-Or,et al. Cytokine‐producing B cells: a translational view on their roles in human and mouse autoimmune diseases , 2016, Immunological reviews.
[11] P. van Paassen,et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. , 2015, Annals of the rheumatic diseases.
[12] C. Kallenberg,et al. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. , 2014, Rheumatology.
[13] Burton E. Barnett,et al. B Cell Antigen Presentation in the Initiation of Follicular Helper T Cell and Germinal Center Differentiation , 2014, The Journal of Immunology.
[14] N. Unterwalder,et al. Effects of sotrastaurin, mycophenolic acid and everolimus on human B‐lymphocyte function and activation , 2012, Transplant international : official journal of the European Society for Organ Transplantation.
[15] J. Nofer,et al. Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus , 2012, Arthritis Research & Therapy.
[16] Y. Li,et al. Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation , 2011, The Journal of Immunology.
[17] V. Tesar,et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. , 2010, JAMA.
[18] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. , 2010, Arthritis and rheumatism.
[19] P. Merkel,et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. , 2010, The New England journal of medicine.
[20] M. Abecassis,et al. Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells. , 2009, Human immunology.
[21] W. Nyhan. Nucleotide Synthesis via Salvage Pathway , 2005 .
[22] C. Lau,et al. Pathogenesis of systemic lupus erythematosus , 2003, Journal of clinical pathology.
[23] Ching-Hon Pui,et al. Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance , 1997, Annals of Internal Medicine.
[24] C. Thompson,et al. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. , 1992, Molecular pharmacology.
[25] J. Hoidal,et al. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. , 1990, Blood.
[26] P. Heeringa,et al. CIRCULATING CD24HICD38HI REGULATORY B-CELLS CORRELATE INVERSELY WITH THE FREQUENCY OF THEM17-CELLS IN GRANULOMATOSIS WITH POLYANGIITIS PATIENTS , 2019 .
[27] P. Merkel,et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.
[28] L. Lennard. The clinical pharmacology of 6-mercaptopurine , 2005, European Journal of Clinical Pharmacology.